Monday, 28 September 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Earnings Call

Osel Devices Earnings Call: Key Takeaways

Osel Devices delivered strong FY26 performance across LED displays, hearing aids, and mobile devices, with a shift toward higher-margin retail and export markets.

Highlights
Revenue growthRevenue grew 56.9% YoY to ₹292.7cr, driven by all three verticals.
MarginsEBITDA margin at 18.2%; retail hearing aids expected to boost profitability.
Demand visibilityStrong visibility in hearing aids and LED command center displays.
Management confidenceConfident, focusing on transition from B2G to high-margin B2C retail.

Growth

Revenue grew 56.9% to ₹292.7cr; EBITDA expanded 57.9% with 18.2% margins despite logistics-driven revenue deferrals.

Outlook

New JNPA SEZ hub commercializing in April 2027 to significantly expand export and OEM capacity.

Risks

Rising debt and interest costs from working capital needs and short-term borrowing against mutual funds; high reliance on government tenders.

Source

Earnings Call filed with NSE, NSE: OSELDEVICE. Summary written with AI assistance from the document.

Read the document ↗

Osel Devices Limited: key numbers

Share price
₹385.90
Market cap
₹686.7 Cr
Revenue (annual)
₹292.7 Cr
Net profit (annual)
₹29.21 Cr
P/E (TTM)
23.5×Sector 45.9×
Promoter holding
64.84%-0.37% QoQ
FII holding
0.18%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Osel Devices Limited

All →
18:42 IST NSE
Annual General Meeting

Osel Devices Annual General Meeting

Osel Devices Limited conducted its 20th Annual General Meeting on September 25, 2026, to transact various agenda items including director re-appointments and capital amendments.

15:03 IST NSE
Annual General Meeting

Osel Devices Annual General Meeting

Osel Devices Limited has scheduled its 20th Annual General Meeting for September 25, 2026. Key agenda items include approving material related party transactions and increasing authorised share capital.

Value
₹50.00 Cr
Execution
FY 2026-27